Vitamin C and Cancer Research: From Hydrogen Peroxide to Clinical Trials
Updated: Oct 19
Research on pharmacological ascorbate has investigated why high vitamin C concentrations can affect certain cancer cells in experimental systems. A laboratory mechanism is important, but it is different from demonstrating a reliable treatment benefit in a person with cancer.
This updated research guide distinguishes the older cell findings from clinical outcomes. It does not recommend replacing oncology treatment with vitamin C.
The hydrogen-peroxide research
A 2016 study by Doskey and colleagues examined hydrogen-peroxide removal and catalase activity across tumor and normal cell lines. The researchers found differences in the cells' ability to handle peroxide and relationships with sensitivity to pharmacological ascorbate.
Those findings help explain a possible mechanism under experimental conditions. They do not mean vitamin C kills every cancer in a patient, selectively spares all normal tissue in practice, or makes a clinic dose an effective cancer treatment.
Clinical results depend on the treatment setting
A small randomized study reported in 2024 found improved survival outcomes when pharmacological ascorbate was added to gemcitabine and nab-paclitaxel for metastatic pancreatic cancer. That result is specific to the regimen and study population and requires careful interpretation.
A separate randomized phase II trial in metastatic castration-resistant prostate cancer did not find improved outcomes from adding high-dose IV vitamin C to docetaxel. The differing results are a reason to avoid presenting one cancer study as evidence for all cancers.
What makes a trial relevant to a patient?
The cancer type and stage.
The concurrent treatment and exact formulation.
The study design, comparator, and number of participants.
The measured outcomes and follow-up.
The screening criteria and reasons some patients were excluded.
Compare those details with your own care only through the treating oncology team. An experimental regimen should not be copied from a blog or adapted from another person's infusion schedule.
Discuss risks and interactions before treatment
The National Cancer Institute's evidence summary discusses both research findings and adverse effects. Review the possibility of interactions and the relevance of G6PD status, kidney history, iron overload, and fluid exposure with the responsible clinicians.
Coordinate care before booking an elective infusion
Do not change chemotherapy, radiation, or other prescribed treatment on the basis of this article. Tell the oncology team about any proposed vitamin C formulation, dose, timing, and other ingredients before proceeding.
For information about our clinic service, contact IV Vitamin Therapy Clinic at 702-966-2440. Eligibility is subject to clinical review. Our service is not a substitute for oncology care, and we do not accept insurance.